Featured Articles
- Dealing with Acute and Chronic Pain While on Methadone
- Downward Trend in Teen Marijuana Use Slows; Prescription Drug Abuse Remains High
- Females Typically Have Different Motivations For Drug Use
- Ecstasy Gets Into the Brain Very Easily
- Harsh Truths About Cocaine
- Suicide Tied to Alcohol Intake
- Rapid Detox - Rapid Opiate Detox - What is it?
- Marijuana's Memory Effects Tied to Misfiring Brain Cells
- Older Men More Likely to Seek Treatment for Alcohol
- What are the medical consequences of drug addiction?
- Study Shows Most Treatment Effective Against Alcoholism
- Neuroimaging Identifies Brain Regions Possibly Involved in Alcohol Craving
- Intermittent Explosive Disorder (IED) Affects up to 16 Million Americans
- PTSD Can Lead to a More Severe Course and Worse Outcomes When Coupled With Substance Abuse
- Substance Use Associated with Low Response to Depression Treatment Among Teens
- What Effects Do Anabolic Steroids Have On Behavior?
Drugs and Memory
Researchers say that drugs may create "extreme" memories by overstimulating the brain's dopamine system, warping an ancient learning system to create addictions.
Harvard University neuroscientist Steven E. Hyman said that dopamine is deeply involved in human survival skills, helping to create memories of essentials like food and water sources. The chemical says to the brain, "This is very important; let's remember exactly how we did this," said Hyman.
When drugs cause an overabundance of dopamine, he said, it may cause the brain to "overlearn," creating a memory of drugs as "good." These memories and associations about drugs can remain strong for a long time, perhaps a lifetime. Hyman spelled out some his theories in an article entitled "Addiction: A Disease of Learning and Memory" in the American Journal of Psychiatry last year, and discussed them further at a recent forum held at the Massachusetts Institute of Technology.
The National Institute on Drug Abuse also is researching the "extreme memory" and "pathological learning" theories, with animal studies aimed at trying to replace unwanted drug memories with new memories to prevent relapse. NIDA director Nora Volkow said that medications that alter memory could "erase the memory of the pleasure associated with the drug." One such medication being tested is D-Cycloserine.
"We often think of treatment as quitting and staying quit," said Shelly F. Greenfield, associate clinical director of the Alcohol and Drug Abuse Treatment Program at McLean Hospital. "Most people, I think, would agree that the quitting part is easier than the staying quit."
